Media Alert: BrainChip Details Olfactory Capabilities of Identifying Bacteria in the Blood in New Research Report
29 Novembre 2023 - 7:30PM
Business Wire
BrainChip Holdings Ltd (ASX: BRN, OTCQX: BRCHF, ADR: BCHPY), the
world’s first commercial producer of ultra-low power, fully
digital, event-based, neuromorphic AI IP, today announced the
availability of a research paper detailing how neuromorphic
computing can be utilized as part of an electric nose system to
detect and identify different bacteria in the blood.
With findings achieved through studies by BrainChip Research,
“Finding Bacteria in the Blood: Scaling a Hardware-Driven
Neuromorphic Solution for Real-World E-Nose Applications” presents
how a hardware-based, low-power neuromorphic solution can be
combined with electronic sensors to create compelling real-world
healthcare solutions that are cost-effective, portable and
accurate. These assisted devices could significantly speed up
disease diagnosis in remote locations, or even outside of
traditional clinical facilities.
The paper explores a blood dataset collected as part of the
Mednose project at Örebro University. The classifier model
developed using Akida™ was able to identify ten different bacteria
species in blood samples with a classification accuracy of 97.42%,
outperforming previous implementations.
“Leveraging neuromorphic hardware to provide portable,
power-efficient solutions for use in the identification of sensory
data is a game-changer for a plethora of practical applications,
such as e-nose systems,” said Anup Vanarse, Research Scientist at
BrainChip. “This latest research paper shows how Akida’s olfactory
analysis technology allows for efficient and accurate detection of
various strains of bacteria in blood to help with important disease
diagnosis. Incorporating beneficial AI within sensory devices will
provide the means for massive breakthroughs in the healthcare
industry.”
Those interested in reading more about neuromorphic solutions
utilized in e-nose applications can download the full research
paper at https://brainchip.com/finding-bacteria-in-blood
About BrainChip Holdings Ltd (ASX: BRN, OTCQX: BRCHF, ADR:
BCHPY)
BrainChip is the worldwide leader in Edge AI on-chip processing
and learning. The company’s first-to-market, fully digital,
event-based AI processor, AkidaTM, uses neuromorphic principles to
mimic the human brain, analyzing only essential sensor inputs at
the point of acquisition, processing data with unparalleled
efficiency, precision, and economy of energy. Akida uniquely
enables Edge learning local to the chip, independent of the cloud,
dramatically reducing latency while improving privacy and data
security. Akida Neural processor IP, which can be integrated into
SoCs on any process technology, has shown substantial benefits on
today’s workloads and networks, and offers a platform for
developers to create, tune and run their models using standard AI
workflows like Tensorflow/Keras. In enabling effective Edge compute
to be universally deployable across real world applications such as
connected cars, consumer electronics, and industrial IoT, BrainChip
is proving that on-chip AI, close to the sensor, is the future, for
its customers’ products, as well as the planet. Explore the
benefits of Essential AI at www.brainchip.com.
Follow BrainChip on Twitter:
https://www.twitter.com/BrainChip_inc
Follow BrainChip on LinkedIn:
https://www.linkedin.com/company/7792006
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231129515377/en/
Media Contact: Mark Smith JPR Communications
818-398-1424
Investor Contact: Tony Dawe Director, Global Investor
Relations BrainChip tdawe@brainchip.com
Barnwell Industries (AMEX:BRN)
Graphique Historique de l'Action
De Avr 2024 à Mai 2024
Barnwell Industries (AMEX:BRN)
Graphique Historique de l'Action
De Mai 2023 à Mai 2024